Adding PER1 or NKX2-6 to the two-gene panel increases sensitivity for DCIS detection to 70%, although decreases sensitivity for early invasive breast cancer (39% and 41%, respectively) detection. The gene discussed is NKX2-6; the disease is ductal breast carcinoma in situ.